Cargando…
Exosome component 1 cleaves single-stranded DNA and sensitizes human kidney renal clear cell carcinoma cells to poly(ADP-ribose) polymerase inhibitor
Targeting DNA repair pathway offers an important therapeutic strategy for Homo sapiens (human) cancers. However, the failure of DNA repair inhibitors to markedly benefit patients necessitates the development of new strategies. Here, we show that exosome component 1 (EXOSC1) promotes DNA damages and...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8260222/ https://www.ncbi.nlm.nih.gov/pubmed/34159897 http://dx.doi.org/10.7554/eLife.69454 |
_version_ | 1783718780957884416 |
---|---|
author | Liu, Qiaoling Xiao, Qi Sun, Zhen Wang, Bo Wang, Lina Wang, Na Wang, Kai Song, Chengli Yang, Qingkai |
author_facet | Liu, Qiaoling Xiao, Qi Sun, Zhen Wang, Bo Wang, Lina Wang, Na Wang, Kai Song, Chengli Yang, Qingkai |
author_sort | Liu, Qiaoling |
collection | PubMed |
description | Targeting DNA repair pathway offers an important therapeutic strategy for Homo sapiens (human) cancers. However, the failure of DNA repair inhibitors to markedly benefit patients necessitates the development of new strategies. Here, we show that exosome component 1 (EXOSC1) promotes DNA damages and sensitizes human kidney renal clear cell carcinoma (KIRC) cells to DNA repair inhibitor. Considering that endogenous source of mutation (ESM) constantly assaults genomic DNA and likely sensitizes human cancer cells to the inhibitor, we first analyzed the statistical relationship between the expression of individual genes and the mutations for KIRC. Among the candidates, EXOSC1 most notably promoted DNA damages and subsequent mutations via preferentially cleaving C site(s) in single-stranded DNA. Consistently, EXOSC1 was more significantly correlated with C>A transversions in coding strands than these in template strands in human KIRC. Notably, KIRC patients with high EXOSC1 showed a poor prognosis, and EXOSC1 sensitized human cancer cells to poly(ADP-ribose) polymerase inhibitors. These results show that EXOSC1 acts as an ESM in KIRC, and targeting EXOSC1 might be a potential therapeutic strategy. |
format | Online Article Text |
id | pubmed-8260222 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | eLife Sciences Publications, Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-82602222021-07-07 Exosome component 1 cleaves single-stranded DNA and sensitizes human kidney renal clear cell carcinoma cells to poly(ADP-ribose) polymerase inhibitor Liu, Qiaoling Xiao, Qi Sun, Zhen Wang, Bo Wang, Lina Wang, Na Wang, Kai Song, Chengli Yang, Qingkai eLife Cancer Biology Targeting DNA repair pathway offers an important therapeutic strategy for Homo sapiens (human) cancers. However, the failure of DNA repair inhibitors to markedly benefit patients necessitates the development of new strategies. Here, we show that exosome component 1 (EXOSC1) promotes DNA damages and sensitizes human kidney renal clear cell carcinoma (KIRC) cells to DNA repair inhibitor. Considering that endogenous source of mutation (ESM) constantly assaults genomic DNA and likely sensitizes human cancer cells to the inhibitor, we first analyzed the statistical relationship between the expression of individual genes and the mutations for KIRC. Among the candidates, EXOSC1 most notably promoted DNA damages and subsequent mutations via preferentially cleaving C site(s) in single-stranded DNA. Consistently, EXOSC1 was more significantly correlated with C>A transversions in coding strands than these in template strands in human KIRC. Notably, KIRC patients with high EXOSC1 showed a poor prognosis, and EXOSC1 sensitized human cancer cells to poly(ADP-ribose) polymerase inhibitors. These results show that EXOSC1 acts as an ESM in KIRC, and targeting EXOSC1 might be a potential therapeutic strategy. eLife Sciences Publications, Ltd 2021-06-23 /pmc/articles/PMC8260222/ /pubmed/34159897 http://dx.doi.org/10.7554/eLife.69454 Text en © 2021, Liu et al https://creativecommons.org/licenses/by/4.0/This article is distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use and redistribution provided that the original author and source are credited. |
spellingShingle | Cancer Biology Liu, Qiaoling Xiao, Qi Sun, Zhen Wang, Bo Wang, Lina Wang, Na Wang, Kai Song, Chengli Yang, Qingkai Exosome component 1 cleaves single-stranded DNA and sensitizes human kidney renal clear cell carcinoma cells to poly(ADP-ribose) polymerase inhibitor |
title | Exosome component 1 cleaves single-stranded DNA and sensitizes human kidney renal clear cell carcinoma cells to poly(ADP-ribose) polymerase inhibitor |
title_full | Exosome component 1 cleaves single-stranded DNA and sensitizes human kidney renal clear cell carcinoma cells to poly(ADP-ribose) polymerase inhibitor |
title_fullStr | Exosome component 1 cleaves single-stranded DNA and sensitizes human kidney renal clear cell carcinoma cells to poly(ADP-ribose) polymerase inhibitor |
title_full_unstemmed | Exosome component 1 cleaves single-stranded DNA and sensitizes human kidney renal clear cell carcinoma cells to poly(ADP-ribose) polymerase inhibitor |
title_short | Exosome component 1 cleaves single-stranded DNA and sensitizes human kidney renal clear cell carcinoma cells to poly(ADP-ribose) polymerase inhibitor |
title_sort | exosome component 1 cleaves single-stranded dna and sensitizes human kidney renal clear cell carcinoma cells to poly(adp-ribose) polymerase inhibitor |
topic | Cancer Biology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8260222/ https://www.ncbi.nlm.nih.gov/pubmed/34159897 http://dx.doi.org/10.7554/eLife.69454 |
work_keys_str_mv | AT liuqiaoling exosomecomponent1cleavessinglestrandeddnaandsensitizeshumankidneyrenalclearcellcarcinomacellstopolyadpribosepolymeraseinhibitor AT xiaoqi exosomecomponent1cleavessinglestrandeddnaandsensitizeshumankidneyrenalclearcellcarcinomacellstopolyadpribosepolymeraseinhibitor AT sunzhen exosomecomponent1cleavessinglestrandeddnaandsensitizeshumankidneyrenalclearcellcarcinomacellstopolyadpribosepolymeraseinhibitor AT wangbo exosomecomponent1cleavessinglestrandeddnaandsensitizeshumankidneyrenalclearcellcarcinomacellstopolyadpribosepolymeraseinhibitor AT wanglina exosomecomponent1cleavessinglestrandeddnaandsensitizeshumankidneyrenalclearcellcarcinomacellstopolyadpribosepolymeraseinhibitor AT wangna exosomecomponent1cleavessinglestrandeddnaandsensitizeshumankidneyrenalclearcellcarcinomacellstopolyadpribosepolymeraseinhibitor AT wangkai exosomecomponent1cleavessinglestrandeddnaandsensitizeshumankidneyrenalclearcellcarcinomacellstopolyadpribosepolymeraseinhibitor AT songchengli exosomecomponent1cleavessinglestrandeddnaandsensitizeshumankidneyrenalclearcellcarcinomacellstopolyadpribosepolymeraseinhibitor AT yangqingkai exosomecomponent1cleavessinglestrandeddnaandsensitizeshumankidneyrenalclearcellcarcinomacellstopolyadpribosepolymeraseinhibitor |